LSI’s Post

View organization page for LSI, graphic

22,439 followers

As the dust settles from years of soaring valuations, our focus shifts to new expectations in 2024. At #LSIUSA24, our expert panelists will unpack the latest developments in valuation and financing, sharing forecasts and current trends that address the 2024 outlook, and provide a deep dive into how these shifts will affect both current and future investment landscapes. We’ll hear perspectives from: • Rik Vandevenne (Moderator), Managing Director, RC Capital, a Healthcare focused growth equity fund, currently investing out of its seventh fund. • Rebecca Raabe, Investment Partner, SPRIG Equity, a growth equity and late-stage venture capital firm dedicated to improving patient outcomes by partnering with best-in-class teams and technologies in the medical technology sector. • Paul McCreadie, Partner & COO Arboretum Ventures, a venture capital firm specializing in the healthcare sector investing throughout the United States, but with a preference for Midwest opportunities. • Matthew Schopp, Senior Director, Business Development, Zimmer Biomet, a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We are still accepting registrations for LSI USA ‘24 on March 18-22 in Dana Point, California. Visit our website to learn more and secure your spot: https://lnkd.in/gjgMpMBh

  • graphical user interface, text

To view or add a comment, sign in

Explore topics